Published in Cancer Weekly, September 26th, 2000
Eighteen of 25 patients who received the complete course of vaccinations demonstrated enhanced antitumor immunity as measured by delayed-type hypersensitivity (DTH) skin reactions. In addition, two patients continue to experience disease-free survival for more than two years after treatment and three other patients were reported...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.